Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

NCT00473460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1404

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases
Bronchitis, Chronic

Interventions

DRUG: Avelox (Moxifloxacin, BAY12-8039)
DRUG: Placebo

Sponsor

Bayer